( September 30, 2025, 4:05 PM EDT) -- NEWARK, N.J. — A New Jersey federal judge refused to reconsider his order that dismissed certain claims in a case alleging that three drug manufacturers engaged in an unfair and unconscionable pricing scheme for their analog insulin products, finding that the “extraordinary remedy” is unwarranted....